First Time Loading...
K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 5.77 CAD
Updated: May 2, 2024

Knight Therapeutics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Knight Therapeutics Inc
Operating Income Peer Comparison

Comparables:
BHC
WEED
CRON
C
CURA
T
TER

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Knight Therapeutics Inc
TSX:GUD
Operating Income
CA$6.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Operating Income
$1.6B
CAGR 3-Years
7%
CAGR 5-Years
26%
CAGR 10-Years
6%
Canopy Growth Corp
TSX:WEED
Operating Income
-CA$337.4m
CAGR 3-Years
25%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Operating Income
-$79.9m
CAGR 3-Years
22%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Operating Income
$12.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Operating Income
-$23.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Knight Therapeutics Inc's Operating Income?
Operating Income
6.4m CAD

Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Operating Income amounts to 6.4m CAD.